Compound Detail
CHEMBL50588
EMETINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21
Basic Information
| ChEMBL ID | CHEMBL50588 |
| Name | EMETINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | AUVVAXYIELKVAI-CKBKHPSWSA-N |
38
Targets
126
Activities
3
Assay Types
0
PK Parameters
20
Publications
10
Known Names
1
Indications
Molecular Properties
480.6
MW (Da)
4.94
ALogP
6
HBA
1
HBD
52.2
PSA (Ų)
0.61
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Withdrawn |
| Chirality | Single Enantiomer |
Indications
Amebiasis
ATC Classification
P01AX02
emetine
Level 1: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Level 2: ANTIPROTOZOALS
P01AX52
emetine, combinations
Level 1: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Level 2: ANTIPROTOZOALS
Drug Warnings
Withdrawn
General Warning
Harmful
Activity Summary
IC50 113 meas. best 9.72
EC50 8 meas. best 8.06
Ki 5 meas. best 7.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| CHO CHEMBL613853 | IC50 | 9.72 | 7.0851 | 0.2 | 39 |
| Unchecked CHEMBL612545 | IC50 | 9.0 | 7.6782 | 1.0 | 11 |
| P388 CHEMBL389 | IC50 | 8.15 | 8.15 | 7.0 | 1 |
| Plasmodium yoelii CHEMBL612889 | IC50 | 8.13 | 8.13 | 7.5 | 1 |
| NS5 CHEMBL4523952 | EC50 | 8.06 | 7.67 | 8.7 | 2 |
| HEK293 CHEMBL614818 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Plasmodium falciparum CHEMBL364 | EC50 | 7.99 | 7.815 | 10.2 | 2 |
| HeLa CHEMBL399 | IC50 | 7.89 | 7.135 | 13.0 | 4 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 7.85 | 7.85 | 14.0 | 1 |
| CHO-K1 CHEMBL614031 | IC50 | 7.7 | 7.05 | 20.0 | 2 |
| DU-145 CHEMBL613508 | IC50 | 7.62 | 7.48 | 24.0 | 4 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 7.58 | 7.58 | 26.0 | 1 |
| LNCaP CHEMBL612518 | IC50 | 7.57 | 7.4825 | 27.0 | 4 |
| PC-3 CHEMBL390 | IC50 | 7.57 | 7.525 | 27.0 | 4 |
| CWR22R CHEMBL612657 | IC50 | 7.51 | 7.51 | 30.8 | 1 |
| HT-29 CHEMBL384 | IC50 | 7.48 | 7.48 | 33.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 7.42 | 7.42 | 38.0 | 1 |
| Trypanosoma brucei CHEMBL612849 | IC50 | 7.4 | 7.4 | 40.0 | 1 |
| A549 CHEMBL392 | IC50 | 7.4 | 7.4 | 40.0 | 1 |
| KB CHEMBL398 | IC50 | 7.4 | 7.325 | 40.0 | 2 |
| ADMET CHEMBL612558 | IC50 | 7.3 | 7.3 | 50.0 | 2 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.3 | 6.92 | 50.0 | 2 |
| Vero CHEMBL391 | IC50 | 7.1 | 6.9833 | 80.0 | 3 |
| Glucose transporter CHEMBL3431938 | IC50 | 7.09 | 7.09 | 81.0 | 1 |
| Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha CHEMBL2221345 | IC50 | 7.08 | 7.02 | 83.0 | 2 |
| Hexose transporter 1 CHEMBL4697 | IC50 | 7.05 | 7.05 | 90.0 | 1 |
| ZR-75-1 CHEMBL614393 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 CHEMBL2535 | IC50 | 6.97 | 6.97 | 108.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 6.74 | 6.74 | 182.0 | 1 |
| Vaccinia virus CHEMBL613493 | EC50 | 6.6 | 6.6 | 250.0 | 1 |
| Human coronavirus OC43 CHEMBL5209665 | EC50 | 6.52 | 6.52 | 300.0 | 1 |
| G-protein coupled receptor 35 CHEMBL1293267 | IC50 | 6.45 | 6.45 | 352.5 | 1 |
| Trypanosoma congolense CHEMBL4296607 | IC50 | 6.37 | 6.37 | 430.0 | 1 |
| Giardia intestinalis CHEMBL612652 | IC50 | 6.1 | 6.0867 | 800.0 | 3 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 5.97 | 5.97 | 1071.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 5.84 | 5.84 | 1430.0 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | IC50 | 5.71 | 5.71 | 1934.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 5.68 | 5.68 | 2094.0 | 1 |
| Entamoeba histolytica CHEMBL612853 | IC50 | 5.66 | 5.66 | 2180.0 | 3 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | IC50 | 5.62 | 5.035 | 2400.0 | 4 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 5.58 | 5.58 | 2642.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 5.18 | 5.18 | 6527.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 5.11 | 5.11 | 7710.0 | 1 |
| Serine hydrolase RBBP9 CHEMBL1075121 | IC50 | 5.11 | 5.11 | 7800.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 296 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 9 |
| 21051535 | 10.1124/dmd.110.034629 | ADMET | 9 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 9 |
| - | 10.6019/CHEMBL5058564 | U2OS | 9 |
| 11602674 | - | ATP-dependent translocase ABCB1 | 7 |
| 11716514 | 10.1006/bbrc.2001.6000 | ATP-dependent translocase ABCB1 | 7 |
| 15974627 | 10.1021/np050029m | Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha | 6 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 5 |
| 29185748 | 10.1021/acs.jmedchem.7b01537 | Plasmodium falciparum | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 5 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 5 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 5 |
Data from ChEMBL 36 via Core Engine